RMC-7977
KRAS inhibitor. Cancer; KRAS, GTPase
BI-3406
SOS1 inhibitor. Cancer; KRAS, GTPase
E3330
APE1 inhibitor/ferroptosis inducer. Cancer; NFkB, Ferroptosis
HD2
DCN1 inhibitor. Focus First-to-Market; Heart disease; NEDDylation
TJ-M2010-5
MyD88 inhibitor. Cancer, Inflammation; TLR signaling, Pyroptosis
C2230
Cav2.2 channel blocker. Focus First-to-Market; Pain; Ion channels
LXG6403
Lysyl oxidase inhibitor. Focus First-to-Market; Cancer; Cell adhesion
MreB Inhibitor A22
Disrupts bacterial actin cytoskeleton. Microbiology, Infectious disease
Pyrintegrin
Enhances stem cell survival / Integrin agonist. Stem cells